Effect of a 12-week home-based exercise protocol on muscle mass, liver and spleen stiffness, and quality of life in patients with liver cirrhosis
Keywords:
Liver cirrhosis, exercise, muscle mass, BMI, liver and spleen stiffness, quality of lifeAbstract
A condition that is characterized by the formation of fibrosis and nodular patterns on the liver due to chronic injury to the liver caused by conditions such as hepatitis, alcoholic liver disease, NASH, etc., is known as liver cirrhosis. A multidimensional approach is always established by exercise towards the betterment of an individual. With the aim of assessing the effect of structured exercise on liver cirrhosis, this study is performed accordingly. A specific formula was taken into consideration to develop a sample size for the participation. A total enrollment of 40 patients was done in this study, who were randomly divided into 2 groups: one was a control group and the other was an experimental group. A simple exercise program was allotted to the control group, and the experimental group underwent a structured exercise program. Outcome measures, which included bioelectric impedance, ultrasound measures for liver and spleen stiffness, and the CLD questionnaire, were assessed before the program as well as after the program. The results were obtained accordingly. The mean muscle mass in the experimental group increased from 24.21 ± 3.99 kg to 30.79 ± 6.44 kg (p < 0.001) with between group difference of p= 0.002 which is considered statistically significant. The mean liver stiffness of experimental group decreased from 11.0 ± 0.82 kPa to 9.32 ± 0.88 kPa (p < 0.001) with between group difference of p= 0.040 suggesting the comparatively greater effectiveness of structured exercise protocol on the patients. The mean spleen stiffness decreased from 30.79 ± 2.72 kPa to 28.42 ± 3.16 kPa (p < 0.001) with between-group post-intervention comparison of 1.18 kPa, which was although modest statistically but significant clinically. While assessing the quality of life of the participant, a statistically significant improvement in fatigue experienced my patient was seen with p value of <0.0001 whereas, the activity symptoms showed p value of 0.05 which was although modest but clinically significant. Thus, promoting the effectiveness of a structured exercise protocol in the betterment of patients with liver cirrhosis
Downloads
Metrics
References
Pedersen BK, Saltin B. Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases. Scandinavian Med Sci Sports. 2015;25(S3):1-72. doi:10.1111/sms.12581
Ruegsegger GN, Booth FW. Health Benefits of Exercise. Cold Spring Harb Perspect Med. 2018;8(7):a029694. doi:10.1101/cshperspect.a029694
Hepatic Cirrhosis - StatPearls - NCBI Bookshelf.
Huang DQ, Terrault NA, Tacke F, et al. Global epidemiology of cirrhosis - aetiology, trends and predictions. Nat Rev Gastroenterol Hepatol. 2023;20(6):388-398. doi:10.1038/s41575-023-00759-2
Le MH, Le DM, Baez TC, et al. Global incidence of adverse clinical events in non-alcoholic fatty liver disease: A systematic review and meta-analysis. Clin Mol Hepatol. 2024;30(2):235-246. doi:10.3350/cmh.2023.0485
Younossi ZM, Golabi P, Paik JM, Henry A, Van Dongen C, Henry L. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335-1347. doi:10.1097/HEP.0000000000000004
Stockdale AJ, Kreuels B, Henrion MYR, et al. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis. J Hepatol. 2020;73(3):523-532. doi:10.1016/j.jhep.2020.04.008
Mondal D, Das K, Chowdhury A. Epidemiology of Liver Diseases in India. Clin Liver Dis (Hoboken). 2022;19(3):114-117. doi:10.1002/cld.1177
Aliwa B, Horvath A, Traub J, et al. Altered gut microbiome, bile acid composition and metabolome in sarcopenia in liver cirrhosis. J Cachexia Sarcopenia Muscle. 2023;14(6):2676-2691. doi:10.1002/jcsm.13342
Gallo P, Flagiello V, Falcomatà A, et al. Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis. J Clin Transl Hepatol. 2024;12(3):278-286. doi:10.14218/JCTH.2023.00207
Gan D, Wang L, Jia M, et al. Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease. Clinical Nutrition. 2020;39(4):1124-1130. doi:10.1016/j.clnu.2019.04.023
Mazeaud S, Zupo R, Couret A, Panza F, Sardone R, Castellana F. Prevalence of Sarcopenia in Liver Cirrhosis: A Systematic Review and Meta-Analysis. Clin Transl Gastroenterol. 2023;14(7):e00584. doi:10.14309/ctg.0000000000000584
Nishikawa H, Enomoto H, Nishiguchi S, Iijima H. Liver Cirrhosis and Sarcopenia from the Viewpoint of Dysbiosis. Int J Mol Sci. 2020;21(15):5254. doi:10.3390/ijms21155254
Tantai X, Liu Y, Yeo YH, et al. Effect of sarcopenia on survival in patients with cirrhosis: A meta-analysis. J Hepatol. 2022;76(3):588-599. doi:10.1016/j.jhep.2021.11.006
Abdelbasset WK, Tantawy SA, Kamel DM, Alqahtani BA, Soliman GS. A randomized controlled trial on the effectiveness of 8-week high-intensity interval exercise on intrahepatic triglycerides, visceral lipids, and health-related quality of life in diabetic obese patients with nonalcoholic fatty liver disease. Medicine (Baltimore). 2019;98(12):e14918. doi:10.1097/MD.0000000000014918
Chien YH, Tsai CJ, Wang DC, Chuang PH, Lin HT. Effects of 12-Week Progressive Sandbag Exercise Training on Glycemic Control and Muscle Strength in Patients with Type 2 Diabetes Mellitus Combined with Possible Sarcopenia. Int J Environ Res Public Health. 2022;19(22):15009. doi:10.3390/ijerph192215009
Lu L, Mao L, Feng Y, Ainsworth BE, Liu Y, Chen N. Effects of different exercise training modes on muscle strength and physical performance in older people with sarcopenia: a systematic review and meta-analysis. BMC Geriatr. 2021;21(1):708. doi:10.1186/s12877-021-02642-8
Shen Y, Shi Q, Nong K, et al. Exercise for sarcopenia in older people: A systematic review and network meta‐analysis. J cachexia sarcopenia muscle. 2023;14(3):1199-1211. doi:10.1002/jcsm.13225
Wang H, Huang WY, Zhao Y. Efficacy of Exercise on Muscle Function and Physical Performance in Older Adults with Sarcopenia: An Updated Systematic Review and Meta-Analysis. Int J Environ Res Public Health. 2022;19(13):8212. doi:10.3390/ijerph19138212
Ajmera V, Kim BK, Yang K, et al. Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants. Gastroenterology. 2022;163(4):1079-1089.e5. doi:10.1053/j.gastro.2022.06.073
Brougham-Cook A, Jain I, Kukla DA, et al. High throughput interrogation of human liver stellate cells reveals microenvironmental regulation of phenotype. Acta Biomater. 2022;138:240-253. doi:10.1016/j.actbio.2021.11.015
Cai C, Song X, Chen X, et al. Transient Elastography in Alcoholic Liver Disease and Nonalcoholic Fatty Liver Disease: A Systemic Review and Meta-Analysis. Can J Gastroenterol Hepatol. 2021;2021:8859338. doi:10.1155/2021/8859338
Ajmera VH, Liu A, Singh S, et al. Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease. Hepatology. 2020;71(3):849-860. doi:10.1002/hep.30974
Ezpeleta M, Gabel K, Cienfuegos S, et al. Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial. Cell Metab. 2023;35(1):56-70.e3. doi:10.1016/j.cmet.2022.12.001
Iwanaga S, Matsuse H, Hashida R, Bekki M, Kawaguchi T, Shiba N. The Effect of Walking Combined with Neuromuscular Electrical Stimulation on Liver Stiffness and Insulin Resistance in Patients with Non-alcoholic Fatty Liver Disease: An Exploratory Randomized Controlled Trial. Kurume Med J. 2023;67(4):137-146. doi:10.2739/kurumemedj.MS674001
Jafarikhah R, Damirchi A, Rahmani Nia F, Razavi-Toosi SMT, Shafaghi A, Asadian M. Effect of functional resistance training on the structure and function of the heart and liver in patients with non-alcoholic fatty liver. Sci Rep. 2023;13(1):15475. doi:10.1038/s41598-023-42687-w
Zhang T, Tian J, Fan J, Liu X, Wang R. Exercise training-attenuated insulin resistance and liver injury in elderly pre-diabetic patients correlates with NLRP3 inflammasome. Front Immunol. 2023;14:1082050. doi:10.3389/fimmu.2023.1082050
Chen Y, Wang W, Wang H, et al. Rapamycin Attenuates Splenomegaly in both Intrahepatic and Prehepatic Portal Hypertensive Rats by Blocking mTOR Signaling Pathway. Alpini G, ed. PLoS ONE. 2016;11(1):e0141159. doi:10.1371/journal.pone.0141159
Hu X, Huang X, Hou J, Ding L, Su C, Meng F. Diagnostic accuracy of spleen stiffness to evaluate portal hypertension and esophageal varices in chronic liver disease: a systematic review and meta-analysis. Eur Radiol. 2021;31(4):2392-2404. doi:10.1007/s00330-020-07223-8
Fierbinteanu-Braticevici C, Tribus L, Peagu R, et al. Spleen Stiffness as Predictor of Esophageal Varices in Cirrhosis of Different Etiologies. Sci Rep. 2019;9(1):16190. doi:10.1038/s41598-019-52407-y
Peagu R, Săraru R, Necula A, Moldoveanu A, Petrişor A, Fierbinţeanu-Braticevici C. The role of spleen stiffness using ARFI in predicting esophageal varices in patients with Hepatitis B and C virus-related cirrhosis. Rom J Intern Med. 2019;57(4):334-340. doi:10.2478/rjim-2019-0017
Grønkjær LL, Lauridsen MM. Quality of life and unmet needs in patients with chronic liver disease: A mixed-method systematic review. JHEP Rep. 2021;3(6):100370. doi:10.1016/j.jhepr.2021.100370
Nagel M, Labenz C, Wörns MA, et al. Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relatives. Health Qual Life Outcomes. 2020;18(1):10. doi:10.1186/s12955-019-1268-9
Nagel M, Weidner V, Schulz S, et al. Continued alcohol consumption and hepatic encephalopathy determine quality of life and psychosocial burden of caregivers in patients with liver cirrhosis. Health Qual Life Outcomes. 2022;20(1):23. doi:10.1186/s12955-022-01923-z
Skladaný Ľ, Líška D, Liptáková E, Tapajčiková T, Vnenčaková J, Koller T. Comparison of the quality of life of patients with liver cirrhosis before and during the COVID-19 lockdown in Slovakia. Sci Rep. 2023;13(1):2463. doi:10.1038/s41598-023-29510-2
Nevhufumba E, Constantinou D, Peter D, Gradidge PJL. The effectiveness of exercise prehabilitation on aerobic capacity, muscle strength and body composition in patients with cirrhosis awaiting liver transplantation: a systematic review and meta-analysis protocol. Syst Rev. 2024;13(1):225. doi:10.1186/s13643-024-02608-y
Dasarathy S. Posttransplant Sarcopenia: An Underrecognized Early Consequence of Liver Transplantation. Dig Dis Sci. 2013;58(11):3103-3111. doi:10.1007/s10620-013-2791-x
Bodine SC, Stitt TN, Gonzalez M, et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol. 2001;3(11):1014-1019. doi:10.1038/ncb1101-1014
Zenith L, Meena N, Ramadi A, et al. Eight Weeks of Exercise Training Increases Aerobic Capacity and Muscle Mass and Reduces Fatigue in Patients With Cirrhosis. Clinical Gastroenterology and Hepatology. 2014;12(11):1920-1926.e2. doi:10.1016/j.cgh.2014.04.016
Román E, Torrades MT, Nadal MJ, et al. Randomized Pilot Study: Effects of an Exercise Programme and Leucine Supplementation in Patients with Cirrhosis. Dig Dis Sci. 2014;59(8):1966-1975. doi:10.1007/s10620-014-3086-6
Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study.
Castera L, Forns X, Alberti A. Non-invasive evaluation of liver fibrosis using transient elastography. Journal of Hepatology. 2008;48(5):835-847. doi:10.1016/j.jhep.2008.02.008
Tarantino G, Finelli C, Colao A, et al. Are hepatic steatosis and carotid intima media thickness associated in obese patients with normal or slightly elevated gamma-glutamyl-transferase? J Transl Med. 2012;10(1):50. doi:10.1186/1479-5876-10-50
Berzigotti A, Garcia-Tsao G, Bosch J, et al. Obesity is an independent risk factor for clinical decompensation in patients with cirrhosis. Hepatology. 2011;54(2):555-561. doi:10.1002/hep.24418
Berzigotti A, Saran U, Dufour J. Physical activity and liver diseases. Hepatology. 2016;63(3):1026-1040. doi:10.1002/hep.28132
Hashida R, Kawaguchi T, Bekki M, et al. Aerobic vs. resistance exercise in non-alcoholic fatty liver disease: A systematic review. Journal of Hepatology. 2017;66(1):142-152. doi:10.1016/j.jhep.2016.08.023
Colecchia A, Montrone L, Scaioli E, et al. Measurement of Spleen Stiffness to Evaluate Portal Hypertension and the Presence of Esophageal Varices in Patients With HCV-Related Cirrhosis. Gastroenterology. 2012;143(3):646-654. doi:10.1053/j.gastro.2012.05.035
Garcia‐Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65(1):310-335. doi:10.1002/hep.28906
Berzigotti A, Seijo S, Arena U, et al. Elastography, Spleen Size, and Platelet Count Identify Portal Hypertension in Patients With Compensated Cirrhosis. Gastroenterology. 2013;144(1):102-111.e1. doi:10.1053/j.gastro.2012.10.001
Stefanescu H, Grigorescu M, Lupsor M, Procopet B, Maniu A, Badea R. Spleen stiffness measurement using fibroscan for the noninvasive assessment of esophageal varices in liver cirrhosis patients. J of Gastro and Hepatol. 2011;26(1):164-170. doi:10.1111/j.1440-1746.2010.06325.x
Younossi ZM, Guyatt G, Kiwi M, Boparai N, King D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut. 1999;45(2):295-300. doi:10.1136/gut.45.2.295
Zenith L, Meena N, Ramadi A, et al. Eight Weeks of Exercise Training Increases Aerobic Capacity and Muscle Mass and Reduces Fatigue in Patients With Cirrhosis. Clinical Gastroenterology and Hepatology. 2014;12(11):1920-1926.e2. doi:10.1016/j.cgh.2014.04.016
Swain MG, Jones DEJ. Fatigue in chronic liver disease: New insights and therapeutic approaches. Liver International. 2019;39(1):6-19. doi:10.1111/liv.13919
Román E, Torrades MT, Nadal MJ, et al. Randomized Pilot Study: Effects of an Exercise Programme and Leucine Supplementation in Patients with Cirrhosis. Dig Dis Sci. 2014;59(8):1966-1975. doi:10.1007/s10620-014-3086-6
Berzigotti A, Saran U, Dufour J. Physical activity and liver diseases. Hepatology. 2016;63(3):1026-1040. doi:10.1002/hep.28132
Deci EL, Ryan RM. The “What” and “Why” of Goal Pursuits: Human Needs and the Self-Determination of Behavior. Psychological Inquiry. 2000;11(4):227-268. doi:10.1207/S15327965PLI1104_01
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
